baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC Knock-Out CHKP/ DE000HS0Q1Z8 /

9/20/2024 9:35:45 PM	Chg.+0.320	Bid9:59:02 PM	Ask9:59:02 PM	Underlying	Strike price	Expiration date	Option type
5.440EUR	+6.25%	5.430 Bid Size: 25,000	5.520 Ask Size: 25,000	Check Point Software...	134.8434 USD	12/31/2078	Call

TeleTrader 9/10 Israeli army stops UN convoy for 8 hours, UNRWA says

GlobeNewswire 9/3 Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and E...

GlobeNewswire 8/30 Carahsoft Sponsors 15th Annual Billington Cybersecurity Summit in Washington, D.C. on September 3-6...

GlobeNewswire 8/29 Anaptys Announces Participation in September Investor Conferences

GlobeNewswire 8/28 Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Pro...

GlobeNewswire 8/28 BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 8/27 Check Point Software to Acquire Cyberint to Transform Security Operations and Expand Managed Threat ...

TeleTrader 8/27 Ukrainian troops allegedly trying to enter Russia near Belgorod

GlobeNewswire 8/14 Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update

GlobeNewswire 8/14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

GlobeNewswire 8/13 Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 8/13 Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma

GlobeNewswire 8/13 PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire 8/13 Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 8/12 Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...

GlobeNewswire 8/12 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...

GlobeNewswire 8/12 Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

GlobeNewswire 8/8 ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 8/8 Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

GlobeNewswire 8/8 PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting

GlobeNewswire 8/8 Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/7 PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024

GlobeNewswire 8/6 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors

GlobeNewswire 8/6 Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire 8/6 BioXcel Therapeutics Reports Second Quarter 2024 Financial Results

HSBC Knock-Out CHKP/ DE000HS0Q1Z8 /

If you wish to receive reply to your feedback, please provide your email address.